RenDing Pharmaceuticals (09688.HK) total revenue in the first quarter was 106 million US dollars, an increase of 22.19% year-on-year.

Wisdom Financial News App: Further Medicine (09688.HK) has released its unaudited performance for the three months ending March 31, 2025. Total revenue was $106 million, a year-on-year increase of 22.19%; research and development expenses were $60.729 million, a year-on-year increase of 11.13%.